Skip to main content
SleepCited

Melatonin için Sirkadiyen Ritim Bozukluğu

A

104 çalışmaya (7 meta-analyses, 6 RCTs), toplam 2,780 katılımcıyla dayanmaktadır. 58/104 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dcircadian\u002Drhythm\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Melatonin is well-supported by strong evidence as a supplement that may help reset disrupted circadian rhythms and internal body clock timing.

  • 104 studies including 7 meta-analyses and 6 RCTs — one of melatonin's best-studied uses
  • Recognized in clinical practice guidelines for circadian rhythm disorders
  • 56% of studies show clearly positive effects; others show mixed or context-dependent results
  • Research covers delayed sleep phase, irregular rhythms, and non-24-hour disorders

Key Study Findings

Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … Etki: None p<0.05

Popülasyon: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … Etki: None None

Popülasyon: None

Case Reports n=1 Open-label
A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome.
Dose: None vs: None Outcome: Sleep-wake phase improvement Etki: None None

Popülasyon: 4-year-old girl with advanced sleep-wake phase disorder

In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes Etki: None None

Popülasyon: Listeria monocytogenes 10403S and ctaP mutant

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management Etki: None None

Popülasyon: Patients with irregular sleep-wake rhythm disorder

Key Statistics

176

Çalışmalar

4513

Katılımcılar

Mixed

A

Derece

Referenced Papers

Handbook of clinical … 2025 10 atıf
JAAPA : official … 2025 1 atıf
Clinical psychopharmacology and … 2024 14 atıf
Current neuropharmacology 2023 38 atıf
Journal of clinical … 2023 6 atıf
Neurologia 2022 78 atıf
Archives of physiology … 2022 69 atıf
Neurologia 2022 47 atıf
Current neuropharmacology 2022 40 atıf
Chronobiology international 2021 47 atıf
Archives of medical … 2021 6 atıf
Neurotherapeutics : the … 2020 80 atıf
Journal of glaucoma 2020 32 atıf
Current treatment options … 2020 29 atıf
Current sleep medicine … 2019 28 atıf
Journal of the … 2019 5 atıf
Neurologic clinics 2019
Current neurology and … 2018 39 atıf
Current biology : … 2017 455 atıf
Neurological research 2017 331 atıf
Continuum (Minneapolis, Minn.) 2017 132 atıf
Current treatment options … 2017 56 atıf
Annual review of … 2016 557 atıf
Neuropsychiatric disease and … 2016 6 atıf
Sleep medicine clinics 2015 75 atıf
Sleep medicine clinics 2015 30 atıf
Medwave 2015 6 atıf
Journal of clinical … 2014 19 atıf
Continuum (Minneapolis, Minn.) 2013 172 atıf
Nihon rinsho. Japanese … 2013
Chronobiology international 2012 1248 atıf
Postgraduate medicine 2011
Expert review of … 2010 58 atıf
The International journal … 2010 55 atıf
Travel medicine and … 2009 101 atıf
Seminars in neurology 2009 17 atıf
Tidsskrift for den … 2009 6 atıf
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 atıf
Behavioral sleep medicine 2007
The FEBS journal 2006 56 atıf
Molecular and cellular … 2006 54 atıf
Journal of biological … 2005 316 atıf
Seminars in neurology 2004 16 atıf
Journal of neuroendocrinology 2003 719 atıf
Best practice & … 2003 339 atıf
The Cochrane database … 2002 154 atıf
Revista de neurologia 2002 35 atıf
Neuro endocrinology letters 2002
The Cochrane database … 2001 154 atıf
The American journal … 2000 472 atıf
Medical science monitor … 2000 11 atıf
Proceedings of the … 1999 96 atıf
Reproduction, nutrition, development 1999 64 atıf
Current treatment options … 1999 23 atıf
European journal of … 1999
Nihon rinsho. Japanese … 1998
Chronobiology international 1997 135 atıf
Medecine tropicale : … 1997
The Netherlands journal … 1996 13 atıf
La Revue du … 1996
Journal of psychiatry … 1994 118 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

Üst sınır: No established UL; 5 mg typically considered maximum

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Positive 55
None -- Neutral --
None -- Mixed --
None -- Positive 1
1.57 and 3.67 mM -- Mixed --
None -- Mixed --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322

En iyi alım zamanı: 30-60 minutes before bed

Safety & Side Effects

Bildirilen Yan Etkiler

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

Bilinen Etkileşimler

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

Tolere edilebilir üst alım: No established UL; 5 mg typically considered maximum

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Melatonin help with Sirkadiyen Ritim Bozukluğu?
Based on 176 studies with 4,513 participants, there is strong evidence from multiple clinical trials that Melatonin may support Sirkadiyen Ritim Bozukluğu management. Our evidence grade is A (Strong Evidence).
How much Melatonin should I take for Sirkadiyen Ritim Bozukluğu?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and Sirkadiyen Ritim Bozukluğu?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 176 peer-reviewed studies with 4,513 total participants. The overall direction of effect is mixed.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.